Bioengineered Metabolic Disruption Systems for Oncological Applications: Devices, Models, and Computational Frameworks

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Emerging engineering solutions are bridging the gap between cancer metabolism theory and clinical translation. This work presents a multi-scale engineering framework to target the Warburg effect. Methods: We developed: A wearable ketone-glucose biosensor (Arduino/CGM hybrid) with 92% concordance to lab assays 3D tumor-on-a-chip models (PDMS microfluidics) simulating nutrient gradients COBRApy metabolic models optimized via TensorFlow for personalized therapy prediction Results: Device data revealed strong inverse correlation between β-hydroxybutyrate (βHB) and tumor growth (r = -0.81, p < 0.001) Microfluidic systems demonstrated 46% reduction in lactate output under ketotic conditions ML models predicted optimal fasting windows with 88.3% accuracy (AUC = 0.91) Impact: This proves the feasibility of closed-loop metabolic engineering systems as adjuvant cancer therapy, with two patents filed for the hardware.

Article activity feed